InMed Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
IMLFF InMed Pharmaceuticals Inc
PNW Pinnacle West Capital Corp
AAPL Apple Inc
NAII Natural Alternatives International Inc
SJMiv.P Invesco BulletShares 2022 Hi Yld Corp Bd ETF
INTC Intel Corp
VAL Valaris PLC
GE General Electric Co
XOM Exxon Mobil Corp
MSFT Microsoft Corp
Go

Health Care : Biotechnology | Small Cap Growth
Based in CanadaCompany profile

InMed Pharmaceuticals Inc. is a pre-clinical-stage biopharmaceutical company. The Company specializes in the research and development of cannabinoid-based therapies combined with drug delivery systems. The Company operates through the segment of research and development of pharmaceutical cannabis based-therapies. The Company is working on two products, which include INM-750, for the treatment of Epidermolysis Bullosa (EB), and INM-085, for the treatment of Glaucoma. The INM-750 is a therapy developed for EB designed specifically to modulate disease activity and to alleviate symptoms. The INM-085 is designed as a dual-action cannabinoid ocular therapy. INM-085 is designed as a topical formulation to be administered directly to the eye. It is working on the development of several cannabinoid-based treatments for multiple diseases, including ocular, dermatology, cancer, inflammation, pain and arthritis disease areas. Its subsidiary is Biogen Sciences Inc. (BSI).

Closing Price
$0.2094
Day's Change
0.0234 (12.58%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.24
Day's Low
0.185
Volume
(Heavy Day)
Volume:
805,287

10-day average volume:
271,100
805,287

Thinking about trading options or stock in Intel, Microsoft, Roku, Tiffany, or Tesla?

9:31 am ET November 25, 2019 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for INTC, MSFT, ROKU, TIF, and TSLA.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- INTC: https://www.investorsobserver.com/pr-options-lp/?stocksymbol=INTC&prnumber=112520191

-- MSFT: https://www.investorsobserver.com/pr-options-lp/?stocksymbol=MSFT&prnumber=112520191

-- ROKU: https://www.investorsobserver.com/pr-options-lp/?stocksymbol=ROKU&prnumber=112520191

-- TIF: https://www.investorsobserver.com/pr-options-lp/?stocksymbol=TIF&prnumber=112520191

-- TSLA: https://www.investorsobserver.com/pr-options-lp/?stocksymbol=TSLA&prnumber=112520191

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

https://c212.net/c/img/favicon.png?sn=CG48284&sd=2019-11-25

View original content:http://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-intel-microsoft-roku-tiffany-or-tesla-300964567.html

SOURCE InvestorsObserver

https://rt.prnewswire.com/rt.gif?NewsItemId=CG48284&Transmission_Id=201911250931PR_NEWS_USPR_____CG48284&DateId=20191125

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.